HistoSonics develops ultrasound-based histotripsy to destroy cancer tumors without surgery
By
Alfonso Maruccia
4d ago· 3 min readenNews
85/100
Golden Brown
Bagelometer↗
Pulled from the oven just right. Trustworthy, fact-dense, deeply satisfying.
Score85TypenewsSentimentpositive
Summary
HistoSonics, founded by biomedical engineer Zhen Xu, is developing histotripsy — a non-invasive technique that uses ultrasound to target and destroy cancerous tumors without surgery. This approach could transform cancer treatment by replacing invasive procedures with safer, less disruptive care. The technology has been in development since 2009 and represents a growing trend of startups exploring novel therapeutic approaches to oncology.
Key quotes
· 3 pulledA China-born researcher is exploring the use of ultrasound to target cancerous cells, potentially turning traditionally invasive procedures into safer, less disruptive forms of care.
HistoSonics, a company founded by biomedical engineer Zhen Xu in 2009, is developing a technique called histotripsy to target different types of cancer.
Startups and researchers around the world are ramping up efforts to develop novel therapeutic approaches to cancer treatment.
HistoSonics, a company founded by biomedical engineer Zhen Xu in 2009, is developing a technique called histotripsy to target different types of cancer. Xu has been refining...
